Eledon Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2015 to Q3 2024.
  • Eledon Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -144 %, a 40.6% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2023 was -289 %, a 336% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2022 was -66.3 %, a 235% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2021 was -19.8 %, a 49.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -144 +98.7 +40.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.22K -2.05K -1211% Apr 1, 2024 Jun 30, 2024
Q1 2024 -720 -641 -811% Jan 1, 2024 Mar 31, 2024
Q4 2023 -289 -223 -336% Oct 1, 2023 Dec 31, 2023
Q3 2023 -243 -218 -867% Jul 1, 2023 Sep 30, 2023
Q2 2023 -169 -146 -618% Apr 1, 2023 Jun 30, 2023
Q1 2023 -79.1 -57.7 -269% Jan 1, 2023 Mar 31, 2023
Q4 2022 -66.3 -46.5 -235% Oct 1, 2022 Dec 31, 2022
Q3 2022 -25.1 -7.67 -43.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -23.6 -4.12 -21.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -21.4 +1.4 +6.13% Jan 1, 2022 Mar 31, 2022
Q4 2021 -19.8 +19.3 +49.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -17.5 +144 +89.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -19.5 +143 +88% Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.8 +130 +85% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.1 +92.1 +70.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -162 -39.5 -32.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -162 -46.1 -39.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -153 -52.1 -51.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -131 -59.7 -83.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -122 -66.7 -120% Jul 1, 2019 Sep 30, 2019
Q2 2019 -116 -64.4 -125% Apr 1, 2019 Jun 30, 2019
Q1 2019 -100 -34.2 -51.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -71.6 -11.2 -18.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -55.5 +35.6 +39.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -51.6 +22.7 +30.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -66.3 -30 -82.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -60.4 +1.38 +2.23% Oct 1, 2017 Dec 31, 2017
Q3 2017 -91.1 -8.48 -10.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -74.3 +11.3 +13.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -36.3 +46.6 +56.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -61.8 +10.9 +14.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -82.6 -36.5 -79% Jul 1, 2016 Sep 30, 2016
Q2 2016 -85.6 -48.8 -133% Apr 1, 2016 Jun 30, 2016
Q1 2016 -82.9 Jan 1, 2016 Mar 31, 2016
Q4 2015 -72.6 Oct 1, 2015 Dec 31, 2015
Q3 2015 -46.2 Jul 1, 2015 Sep 30, 2015
Q2 2015 -36.8 Apr 1, 2015 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.